EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Weight loss at a cost: Semaglutide and PYY3-36 aggravate pre-existing metabolic osteoporosis in female Wistar rats

Simon Kloock, Palina Zytner, Niklas Geiger, Vasco Sequeira, Angelika G Schmitt-Böhrer, Jasmin Felker, Humma Sarwar, Alexander Weich, Anita Ignatius, Martin Fassnacht, Melanie Haffner-Luntzer, Ulrich Dischinger

Bone · 2027-03 · 216 · 118170

DOI: 10.1016/j.bone.2026.118170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone, 2027-03. Verfasst von Simon Kloock und 11 weiteren Autor:innen. Beteiligte Einrichtung: University of Wuerzburg, University Hospital Wuerzburg, Department of Internal Medicine, Division of Endocrinology and Diabetes, Wuerzburg, Germany. …. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bristol-Myers Squibb Company, German Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Animal researchL-NAMEMetabolic osteoporosisOsteoporosisPYYSemaglutideSteroid hormones

Autor:innen und Institutionen

  • University of Wuerzburg, University Hospital Wuerzburg, Department of Internal Medicine, Division of Endocrinology and Diabetes, Wuerzburg, Germany. Electronic address: kloock_s@ukw.de.
  • University of Wuerzburg, University Hospital Wuerzburg, Department of Internal Medicine, Division of Endocrinology and Diabetes, Wuerzburg, Germany.
  • University of Wuerzburg, University Hospital Wuerzburg, Comprehensive Heart Failure Center, Wuerzburg, Germany.
  • University of Wuerzburg, University Hospital Wuerzburg, Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, Wuerzburg, Germany.
  • University of Wuerzburg, University Hospital Wuerzburg, Department of Internal Medicine, Division of Endocrinology and Diabetes, Wuerzburg, Germany; University of Wuerzburg, University Hospital Wuerzburg, Core Unit Clin…
  • Institute of Orthopaedic Research and Biomechanics, University of Ulm, Ulm, Germany.

Förderung

  • Bristol-Myers Squibb Company
  • German Research Foundation

Zitieren

APA

Kloock, S., Zytner, P., Geiger, N., Sequeira, V., Schmitt-Böhrer, A. G., Felker, J., Sarwar, H., Weich, A., Ignatius, A., Fassnacht, M., Haffner-Luntzer, M., & Dischinger, U. (2027). Weight loss at a cost: Semaglutide and PYY3-36 aggravate pre-existing metabolic osteoporosis in female Wistar rats. Bone, 216, 118170. https://doi.org/10.1016/j.bone.2026.118170

Vancouver

Kloock S, Zytner P, Geiger N, Sequeira V, Schmitt-Böhrer AG, Felker J, et al. Weight loss at a cost: Semaglutide and PYY3-36 aggravate pre-existing metabolic osteoporosis in female Wistar rats. Bone. 2027;216:118170. doi:10.1016/j.bone.2026.118170

BibTeX
@article{Kloock2027,
  author = {Kloock, Simon and Zytner, Palina and Geiger, Niklas and Sequeira, Vasco and Schmitt-Böhrer, Angelika G and Felker, Jasmin and Sarwar, Humma and Weich, Alexander and Ignatius, Anita and Fassnacht, Martin and Haffner-Luntzer, Melanie and Dischinger, Ulrich},
  title = {Weight loss at a cost: Semaglutide and PYY3-36 aggravate pre-existing metabolic osteoporosis in female Wistar rats},
  journal = {Bone},
  year = {2027},
  volume = {216},
  pages = {118170},
  doi = {10.1016/j.bone.2026.118170}
}
Kostenlos starten →